Shares in Generic-Drug Makers Fall After Trump’s Tariff Plan
Shares in several European and Asian makers of generic medicines fell after President Trump said the U.S. would place tariffs on such drugs starting in August 2028.
The Source
TWSJ
Business
AMD and Anthropic Sign Major Chips-and-Investment Deal
TWSJ·40m ago·3 min read
Business
Lloyd’s of London Criticizes Former CEO’s Close Relationship With Subordinate
TWSJ·13m ago·3 min read
Health
A controversial arbitration process intended to protect patients from surprise bills generated nearly $15 billion in payouts last year, according to new federal data
TWSJ·1h ago·3 min read
Business
Kone Confirms Guidance Despite Costs of TK Elevator Acquisition
TWSJ·43m ago·3 min read
Related
On this beat
Health
A controversial arbitration process intended to protect patients from surprise bills generated nearly $15 billion in payouts last year, according to new federal data
TWSJ·1h ago·3 min read
Health
Government Overhauls Teen Pregnancy Program to Focus on Marriage and Starting Families
TNYT·4h ago·3 min read
Health
Cardinal Health’s latest deals won’t move the needle overnight. They still matter.
CNBC·19h ago·3 min read
Health
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
CNBC·22h ago·3 min read